4//SEC Filing
Madan Ajay 4
Accession 0001209191-21-062263
CIK 0001658247other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 7:11 PM ET
Size
7.3 KB
Accession
0001209191-21-062263
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-28$0.73/sh+106,383$77,660→ 184,671 total - Exercise/Conversion
Stock Option (right to buy)
2021-10-28−106,383→ 0 totalExercise: $0.73Exp: 2028-03-16→ Common Stock (106,383 underlying)
Footnotes (2)
- [F1]Includes 772 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
- [F2]25% of the shares subject to the option vested on July 17, 2017 and 1/48th of the total remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001807856
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 7:11 PM ET
- Size
- 7.3 KB